Symbol
| PCK1
| contributors: mct - updated : 15-05-2020
|
HGNC name
| phosphoenolpyruvate carboxykinase 1 (soluble)
|
HGNC id
| 8724
|
corresponding disease(s)
|
PCKDC
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
lower in clinical hepatocellular carcinoma (HCC) tissues than that in normal tissues | |
Susceptibility
|
to type 2 diabetes mellitus to late-onset Alzheimer's disease |
Variant & Polymorphism
SNP
| promoter SNP associated with type 2 diabetes mellitus |
|
|
Candidate gene
Marker
| PCK1 may serve as a candidate prognostic biomarker in clear cell renal cell carcinoma (ccRCC) | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | urinary | | |
targeting the PCK1/LDHA pathway might be a new strategy to selectively inhibit tumor metabolism in in clear cell renal cell carcinoma | cancer | digestive | colon | |
DHODH and PCK1 are metabolic therapeutic targets in Colorectal metastatic progression |
| | |